Veracyte, Inc.
VCYT- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001384101
In the last 90 days, Veracyte, Inc. insiders filed 0 open-market purchases and 6 sales; 370 institutions reported holding it in 13F filings for Q2 2026, worth $5.23B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q2 2025
Institutional positions in Veracyte, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 278
- −7 vs. Q1 2025
- Shares held
- 85.4M
- +673.3K (+0.8%) vs. Q1 2025
- Total value
- $2.31B
- −$203.5M (−8.1%) vs. Q1 2025
- New holders
- 36
- 102 more added
- Sold out
- 43
- 103 more reduced
2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VCYT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 370 | $5.23B |
| Q1 2026 | 334 | $2.84B |
| Q4 2025 | 329 | $3.65B |
| Q3 2025 | 298 | $3.08B |
| Q2 2025 | 278 | $2.31B |
| Q1 2025 | 287 | $2.51B |
| Q4 2024 | 318 | $3.25B |
| Q3 2024 | 293 | $2.78B |
| Q2 2024 | 240 | $1.78B |
| Q1 2024 | 246 | $1.82B |
| Q4 2023 | 250 | $2.13B |
| Q3 2023 | 237 | $1.72B |
| Q2 2023 | 232 | $1.96B |
| Q1 2023 | 233 | $1.74B |
| Q4 2022 | 223 | $1.81B |
| Q3 2022 | 208 | $1.28B |
| Q2 2022 | 194 | $1.52B |
| Q1 2022 | 204 | $2.11B |
| Q4 2021 | 217 | $3.10B |
| Q3 2021 | 215 | $3.47B |
| Q2 2021 | 215 | $2.91B |
| Q1 2021 | 235 | $3.93B |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Veracyte, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Verition Fund Management LLC | 0 | $0 | 0.00% | −8,807−100.0% | Sold out |
| Keybank National Association | 0 | $0 | 0.00% | −8,690−100.0% | Sold out |
| Ieq Capital, LLC | 0 | $0 | 0.00% | −8,032−100.0% | Sold out |
| SIH Partners, LLLP | 0 | $0 | 0.00% | −7,500−100.0% | Sold out |
| Xponance, Inc. | 0 | $0 | 0.00% | −6,860−100.0% | Sold out |
| Neo Ivy Capital Management | 0 | $0 | 0.00% | −5,838−100.0% | Sold out |
| Asset Management One Co.,Ltd. | 0 | $0 | 0.00% | −4,943−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −1,350−100.0% | Sold out |
| Ci Investments Inc. | 0 | $0 | 0.00% | −1,272−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −158−100.0% | Sold out |
| Mather Group, LLC. | 0 | $0 | 0.00% | −130−100.0% | Sold out |
| Bokf, NA | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −55−100.0% | Sold out |
| Cordant, Inc. | 0 | $0 | 0.00% | −63−100.0% | Sold out |
| Continuum Advisory, LLC | 0 | $0 | 0.00% | −58−100.0% | Sold out |
| Carolinas Wealth Consulting LLC | 0 | $0 | 0.00% | −47−100.0% | Sold out |
| Private Wealth Asset Management, LLC | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| Stephens Consulting, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Global Financial Private Client, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| CAPROCK Group, Inc. | – | – | – | – | Not filed |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |